Country

Title

Patent No./Application No.

US

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation PatentNo. 9,468,603

US

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation Patent No.8,716,328

US

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation Patent No. 10,064,823

Australia

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 2012275953

Canada

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 2,836,914

China

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No.

ZL 2012800280815

Europe

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Validated in UK, France and Germany

India

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 31673

Japan

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 5621071

S. Korea

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 1444693

Mexico

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 337464

New Zealand

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 618596

Singapore

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 195018

Vietnam

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 16328

Vietnam

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Appl. No. 1-2014-01570

Patent No. 17042

US

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 8,440,714

US

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 8,716,328

US

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 9,339,555

US

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 9,889,201

US

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Patent No. 10,172,957